arrow
J

Jienchi Dorward

university of washington
H指数:28
被引数:4,147

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring: qualitative findings from a randomized controlled trial in South Africa

对基于诊所的尿液替诺福韦检测用于抗逆转录病毒疗法依从性监测的接受度和前景:来自南非一项随机对照试验的定性研究结果

2026-05-010
PRE
Uptake and 24-month Outcomes of Dolutegravir- Versus Lopinavir-based Second-line Antiretroviral Therapy for People With HIV in South Africa: A Retrospective Cohort Study and Emulated Target Trial

南非人群中HIV患者中,度鲁特格拉韦与洛匹那韦为基础的二线抗逆转录病毒疗法的使用及24个月结局:一项回顾性队列研究和模拟目标试验

2025-09-010
OAAI
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
2024-10-010
OAAI
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

伊维菌素用于社区成人新型冠状病毒肺炎 (原则): 一项开放、随机、对照、适应性的短期和长期结果平台试验

2024-04-015
OAAI
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

molnupiravir在高危成人门诊患者中SARS-CoV-2病毒和抗体反应的随机对照试验

2024-02-2310
OAAI
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial

莫那比拉韦对高危社区新型冠状病毒肺炎成人的成本效用分析: 全景试验的经济评估

2024-01-162
OAAI
Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study

基于dolutegavir的一线抗逆转录病毒疗法在南非HIV感染者中的实施和结果: 一项回顾性队列研究

2023-05-0125
OAAI
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
LANCET
IF88.5
2023-01-01237
OAAI
Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial

护理点测试对南非性传播感染管理的影响: 来自HVTN702人类免疫缺陷病毒疫苗试验的证据

2022-10-177
OAAI
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
2022-03-2328
OAAI
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
2021-09-0155
OAAI
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
LANCET
IF88.5
2021-09-01157
OAAI
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
LANCET
IF88.5
2021-03-01190
OAAI